ArticleActa dermato-venereologica2026

Prior Specific Biologic Use as a Potential Risk Factor for Administration-related Reactions to Ixekizumab after Excipient Modification: A Single-centre Retrospective Study.

Hiroyoshi Nozaki et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.